Page last updated: 2024-09-02

ci 988 and Experimental Neoplasms

ci 988 has been researched along with Experimental Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Howes, LG; Morris, DL; Romani, R	1

Other Studies

1 other study(ies) available for ci 988 and Experimental Neoplasms

Article	Year
Gastrin receptor antagonist CI-988 inhibits growth of human colon cancer in vivo and in vitro. The Australian and New Zealand journal of surgery, 1996, Volume: 66, Issue:4 Topics: Administration, Oral; Analysis of Variance; Animals; Cell Division; Colorectal Neoplasms; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Receptors, Cholecystokinin; Tumor Cells, Cultured	1996

Article

Year

Gastrin receptor antagonist CI-988 inhibits growth of human colon cancer in vivo and in vitro.

The Australian and New Zealand journal of surgery, 1996, Volume: 66, Issue:4

Topics: Administration, Oral; Analysis of Variance; Animals; Cell Division; Colorectal Neoplasms; Drug Evaluation, Preclinical; Hormone Antagonists; Humans; Indoles; Male; Meglumine; Mice; Mice, Nude; Neoplasms, Experimental; Receptors, Cholecystokinin; Tumor Cells, Cultured

1996